FSLLRY-NH2 TFA is a protease-activated receptor 2 (PAR2) inhibitor.
体内研究
Treatment with FSLLRY-NH2 (50 μg per rat administered intranasally at 1 hour postresuscitation) significantly improves neurological outcome and reduces the number of degenerating hippocampal neurons after ACA (asphyxial CA).
运输条件
Room temperature in continental US; may vary elsewhere.